loading

First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten

pulisher
Sep 07, 2026

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - mexc.co

Sep 07, 2026
pulisher
Sep 04, 2026

First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView

Sep 04, 2026
pulisher
Sep 04, 2026

First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan

Sep 04, 2026
pulisher
Sep 03, 2026

H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo

Sep 03, 2026
pulisher
Sep 03, 2026

TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus

Sep 03, 2026
pulisher
Sep 02, 2026

Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Sep 02, 2026
pulisher
Sep 02, 2026

Which stocks are gapping on Wednesday? - ChartMill

Sep 02, 2026
pulisher
Aug 27, 2026

Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Aug 27, 2026
pulisher
Aug 26, 2026

EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

First Tracks Biotherapeutics Announces Participation in September Investor Conferences - finance.yahoo.com

Aug 26, 2026
pulisher
Aug 26, 2026

Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 26, 2026
pulisher
Aug 25, 2026

Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Aug 25, 2026
pulisher
Aug 25, 2026

Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Aug 25, 2026
pulisher
Aug 25, 2026

Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Aug 25, 2026
pulisher
Aug 25, 2026

Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

EBITDA per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Enterprise value to EBIT forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Operating expenses (excl. COGS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 25, 2026

Diluted net income available to common stockholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Aug 25, 2026
pulisher
Aug 24, 2026

AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet

Aug 24, 2026
pulisher
Aug 20, 2026

J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 - Moomoo

Aug 20, 2026
pulisher
Aug 20, 2026

Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95 - Moomoo

Aug 20, 2026
pulisher
Aug 20, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 20, 2026
pulisher
Aug 18, 2026

First Tracks Biotherapeutics CBO Benjamin Stone Receives 60,492 Performance Stock Units - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

First Tracks Biotherapeutics' CMO Paul F. Lizzul Earns 60,492 Performance Stock Units Following Certified Milestones - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

First Tracks Biotherapeutics CEO Daniel Faga Awarded 193,575 Performance Stock Units - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

First Tracks (TRAX) insider records new share trades - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

First Tracks Biotherapeutics (TRAX) insider updates holdings - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

First Tracks Biotherapeutics (TRAX) insider logs trades - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

FIRST TRACKS BIOTHERAPEUTICS INC : JP MORGAN RAISES TARGET PRICE TO $65 FROM $30 - Moomoo

Aug 18, 2026
pulisher
Aug 18, 2026

Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX) - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Wolfe Research initiates First Tracks stock with outperform rating By Investing.com - Investing.com Canada

Aug 18, 2026
pulisher
Aug 18, 2026

We're Hopeful That First Tracks Biotherapeutics (NASDAQ:TRAX) Will Use Its Cash Wisely - Sahm

Aug 18, 2026
pulisher
Aug 17, 2026

Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits

Aug 17, 2026
pulisher
Aug 16, 2026

AnaptysBio earnings ahead: First results as royalty company By Investing.com - Investing.com Australia

Aug 16, 2026
pulisher
Aug 16, 2026

AnaptysBio earnings ahead: First results as royalty company - Investing.com

Aug 16, 2026
pulisher
Aug 13, 2026

First Tracks Biotherapeutics (NASDAQ: TRAX) Share Price, TRAX Stock News, TRAX Share Price & Updates - kalkine.ca

Aug 13, 2026
pulisher
Aug 13, 2026

TRAX SEC FilingsFirst Tracks Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $63.38, Implies 37% Upside - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Piper Sandler raises First Tracks stock price target on pipeline progress - Investing.com Australia

Aug 13, 2026
pulisher
Aug 13, 2026

TRAX Maintained by First Tracks -- Price Target Raised to $95.00 - GuruFocus

Aug 13, 2026
pulisher
Aug 13, 2026

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results - Benzinga

Aug 13, 2026
pulisher
Aug 13, 2026

A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95 - Moomoo

Aug 13, 2026
pulisher
Aug 13, 2026

TRAX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00 - GuruFocus

Aug 13, 2026
pulisher
Aug 13, 2026

Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $60.5, Implies 31% Upside - tradingview.com

Aug 13, 2026
$60.42
price down icon 0.29%
$129.71
price up icon 4.16%
$42.02
price up icon 1.47%
$255.62
price down icon 1.76%
ONC ONC
$350.05
price down icon 0.44%
$209.85
price up icon 1.19%
Kapitalisierung:     |  Volumen (24h):